Pharming Leniolisib Launch Will Require Identifying Patients With Ultra Rare APDS

 
• By Alaric DeArment
  
Pharming sees leniolisib as a way to expand its US and global commercial footprint • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Strategy

More from Business